Few studies have compared resource consumption and costs associated with haemodialysis (HD) and peritoneal dialysis (PD) access. Here we report results from a retrospective analysis titled: Cost analysis of haemodialysis and peritoneal dialysis access in incident dialysis patients1 comparing these treatments in the first year of therapy that may have important implications for policymakers.
High Volume HDF improves patient survival
The Catalonian Online Haemodiafiltration Survival Study (ESHOL) published in February 2013 confirms Fresenius Medical Care’s conviction that every patient should be given the chance to benefit from haemodiafiltration (HDF) therapy with high volumes of substitution fluid (HighVolumeHDF). The primary outcome of the study was that HighVolumeHDF therapy significantly improves patient survival compared with conventional dialysis treatment. At this year’s ERA-EDTA Congress, HighVolumeHDF was the main focus of Fresenius Medical Care’s activities.
New ISO Standards for haemodialysis fluids. Are you compliant?
Fresenius Medical Care Australia launched their new Water Testing Guidelines at a recent forum aimed to assist clinicians and technicians in their daily clinical practice. The 60 participants learnt how to apply them, in parallel to achieving the five ISO Standards relating to the quality of fluid for haemodialysis. A feature segment of the forum was from two scientists that presented on techniques used to analyse endotoxin and bacterial levels.
With the help of Automated Peritoneal Dialysis Kevin was able to turn a dream into reality and visit some of the wonderful sites of Australia. This is his story.
This is the story of an amazing little boy from Malaysia making the most of an unfortunate situation with the help of his loving parents. The story is written from the perspective of a mother who would move heaven and earth to give her son the best life he could have. The following tells of how this little boy’s big dream became a reality and the positive impact an APD (Automated Peritoneal Dialysis) machine had on his quality of life.
The new Catalonian High Volume Online Haemodiafiltration (OL-HDF) study shows that High Volume OL-HDF therapy improves patients’ survival rate. With a 30% reduction of all-cause mortality and 33% lower risk of cardiovascular mortality patients should benefit from High Volume Online HDF.